ANDA Stability Final Guidance Arrives With Few Answers for Industry
This article was originally published in The Tan Sheet
Executive Summary
With few changes from the draft and without the promised question-and-answer document, industry may still clamor for more. FDA recommends generic drug manufacturers follow the stability testing recommendations in International Conference on Harmonization guidances.